Avrobio Plots Comeback With Early Data From Gaucher’s Gene Therapy

Sees Bluebird Success As Creating Pathway

 
• By Andrew McConaghie
  
Avrobio
Avrobio is looking to revive its fortunes by developing a Gaucher's gene therapy. • Source: Shutterstock

More from Business

More from Scrip